Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
560
-
Total 13F shares, excl. options
-
36.9M
-
Shares change
-
-54K
-
Total reported value, excl. options
-
$19.1B
-
Value change
-
-$21.6M
-
Put/Call ratio
-
0.76
-
Number of buys
-
242
-
Number of sells
-
-253
-
Price
-
$517.34
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q4 2021
636 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q4 2021.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 560 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.9M shares
of 152M outstanding shares and own 24.2% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.43M shares), BlackRock Inc. (4.33M shares), STATE STREET CORP (1.61M shares), BAMCO INC /NY/ (1.48M shares), Neuberger Berman Group LLC (1.09M shares), BROWN CAPITAL MANAGEMENT LLC (987K shares), FRED ALGER MANAGEMENT, LLC (962K shares), Ownership Capital B.V. (891K shares), GEODE CAPITAL MANAGEMENT, LLC (763K shares), and MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (728K shares).
This table shows the top 560 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.